Back to All Speakers

Nancy Rigotti, MD

Director of Multiple Areas, Massachusetts General Hospital & Harvard Medical School

Associate Chief of the Division of General Internal Medicine, Director of the Office of Women’s Careers, and Director of the Tobacco Research and Treatment Center, Massachusetts General Hospital & Harvard Medical School

Dr. Rigotti is a primary care physician who trained in internal medicine at Massachusetts General Hospital (MGH), where she is Director of the Office of Women’s Careers and Associate Chief of the Division of General Internal Medicine, and a Professor of Medicine at Harvard Medical School. An internationally-known expert on tobacco use and treatment, Dr. Rigotti has long advocated for improving the delivery of tobacco dependence treatment in the health care system. She founded and directs MGH’s Tobacco Research and Treatment Center, which combines a clinical treatment program, the MGH Tobacco Treatment Service, with a multidisciplinary research group that develops, test, and disseminate interventions for smoking cessation across outpatient and inpatient settings. Working at the junction of medicine and public health, Dr. Rigotti’s work combines efforts to change individual behavior with community, policy, and health care system efforts to influence individuals’ decisions about starting or continuing to smoke.

Dr. Rigotti has served as President of the Society of General Internal Medicine (2008-09) and president of the Society for Research in Nicotine and Tobacco (2003-04). She has served on numerous national and international committees addressing tobacco issues. Awards include the 2015 John Eisenberg National Award for Career Achievement in Research from the Society of General Internal Medicine and the 2006 James D. Bruce Memorial Award for Distinguished Contributions in Preventive Medicine from the American College of Physicians.

Previous Sessions

Monday, May 23, 2016

Pharmacotherapy

Presenters provide a review of tobacco dependence pharmacotherapy with a focus on use in the hospital setting, use in people with serious mental illness, the role pharmacy professionals play in implementation of pharmacotherapy treatment, and the challenges of pharmacotherapy treatments in low resource settings.